Bottom of the canal: Pfizer’s billion-dollar tax rort
New York pharma giant Pfizer has engaged in a series of paper transactions to create artificial share capital and a $936 million loss in Australia.
Bottom of the canal: Pfizer’s billion-dollar tax rort
New York pharma giant Pfizer has engaged in a series of paper transactions to create artificial share capital and a $936 million loss in Australia.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
